NASDAQ
CASI Pharmaceuticals, Inc. (CASI) has a eps (basic) of $-2.56 as of Tuesday, December 31, 2024. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.